Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2339-2344

  Tserkezoglou, Aliki ^a,d   Kontou, Sofia ^b   Hadjieleftheriou, George ^a   Apostolikas, Nikiforos ^a   Vassilomanolakis, Michalis ^a   Sikiotis, Konstantinos ^b   Salamalekis, Emmanouel ^b   Tseke, Paraskevi ^c   Magiakos, George ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Hatzikosta Hospital   (Greece)

^d NONE   (Greece)

Author keywords

BRCA1 2 mutations; Double primary breast ovarian cancer; Metastatic breast cancer; Ovarian cancer; Pre operative diagnosis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN;

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MEDICAL RECORD; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CA-125 ANTIGEN; CA-15-3 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS;

EID: 33745535228     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Murray T, Sammuels A, Ghafoor A, Ward E and Thun MJ: Cancer Statistics 2003. Cancer J Clin 53: 5-26, 2003.
2. Bergfelt K, Rydh B, Granath F, Gronberg H, Thalib L, Adami H-O and Hall P: Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population - based cohort study. Lancet 360: 891-894, 2002.
3. Webb MJ, Decker DG and Mussey E: Cancer metastatic to the ovary - factors influencing survival. Obstet Gynecol 45: 391-396, 1975.
4. Demopoulos RI, Tonger L and Dubin N: Secondary ovarian carcinoma: a clinical and pathologic evaluation. Int J Gynecol Pathol 6: 166-175, 1987.
5. Olawaiye A, Caesar L, Walsh D, Lyman M, Yeh J, Rodabaugh K, Marchetti D, Lele S and Odunsi K: Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers. Gynecol Oncol 94 (3): 796-802, 2004.
6. Rubin SC, Benjamin I, Behbakht K et al: Clinical and pathological features of ovarian cancer in women with germline mutations of BRCA1. N Engl J Med 335: 1413-1416, 1996.
7. Aida H, Takakuwa K, Nagata H et al: Clinical features of ovarian cancer in Japanese women with germ-line mutationa of BRCA1. Clin Cancer Res 4: 235-240, 1998.
8. Boyd J, Sonoda Y, Federici MG et al: Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283: 2260-2265, 2000.
9. Berry DA, Iversen ES Jr, Gudbjartson DF et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2 and prevalence of either breast cancer susceptibility genes. J Clin Oncol 20: 2701-2712, 2002.
10. Euhus M, Smith KC, Robinson et al: Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94: 844-851, 2002.
11. Kaplan E and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
12. Abu-Rustum NR, Aghajanian CA, Venkatraman ES, Feroz F and Barakat RR: Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol 66: 41-44, 1997.
13. Raab R, Nussbaum KT, Behrend M and Weimann A: Liver metastases of breast cancer: results of liver resection. Anticancer Res 18: 2231-2234, 1998.
14. Pappo I, Feigin E, Uziely B and Amir G: Billiary and pancreatic metastases of breast carcinoma: is surgical palliation indicated? J Surg Oncol 46: 211-214, 1991.
15. Curtin JP, Barakat RR and Hoskins WJ: Ovarian disease in women with breast cancer. Obstet Gynecol 84: 449-452, 1994.
16. Eitan R, Gemignani ML, Venkatraman ES, Barakat RR and Abu-Rustum N: Breast cancer metastatic to abdomen and pelvis: role of surgical resection. Gynecol Oncol 90: 397-401, 1991.
17. Cagnon Y and Tetu B: Ovarian metastasis of breast carcinoma: a clinicopathologic study of 59 cases. Cancer 64: 892-898, 1989.
18. Fishman A, Dekel E, Chetrit A, Geva LL, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing J and Modan B: Patients with double primary tumors in the breast and ovary - clinical characteristics and BRCA 1-2 mutations status. Gynecol Oncol 79: 74-78, 2000.
19. Frank TS, Manley SA, Olopade OI et al: Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16: 2417-2425, 1998.
20. Whittemore AS, Gong G and Ithyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results of three US population based cases control studies of ovarian cancer. Am J Hum Genet 60: 496-504, 1997.
21. Stratton JF, Gayther SA, Russell P et al: Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336: 1125-1130, 1997.
22. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N and Peretz T: The founder mutations 185delAG and 5382INSc in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60: 505-514, 1997.
23. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neill e, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH and Haber DA: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334: 143-149, 1996.
24. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Horneich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A and Halle D: Founder recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60: 1059-1067, 1997.
25. Hann LE, Lui DM, Shi W, Bach AM, Selland DL and Castiel M: Adnexal masses in women with breast cancer: US findings with clinical and histopathological correlation. Radiology 216(1): 242-247, 2000.
26. Perrotin F, Marret H, Bouquin R, Fischer-Perrotin N, Lansac J and Body G: Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer. Gynecol Obstet Fertil 29(4): 308-315, 2001.
27. McGuire V, Whittemore AS, Norris R and Oakley-Girvan I: Survival in epithelial ovarian cancer patients with prior breast cancer. Am J Epidemiol 152(6): 528-532, 2000.
28. Ayhan A, Tuncer S and Bukulmez O: Malignant tumors metastatic to the ovaries. J Surg Oncol 60: 268-276, 1995.
29. Petru E, Pickel H, Heydarfadai M, Lahousen M, Hass J, Schaider H and Tamussino K: Nongenital cancers metastatic to the ovary. Gynecol Oncol 44: 83-86, 1992.